OpenAlex
PricingAboutJobs
Log inGet started
Work

A novel cytidine analog, RX-3117, shows potent efficacy in xenograft models, even in tumors that are resistant to gemcitabine.

PubMed

Year: 2014
Type: article
Source: PubMed
Authors: Mi Young Yang, Young Bok Lee, Chang-Ho Ahn, Joel Kaye, Tania Fine, Rina Kashi, Osnat Ohne, Kees Smid, Godefridus J Peters, Deog Joong Kim
Institutions: Teva Pharmaceuticals (Israel), Amsterdam UMC Location Vrije Universiteit Amsterdam
Language: English

Topic: Cancer therapeutics and mechanisms
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: cytidine analogs, gemcitabine resistance, oral anticancer drugs, tumor xenografts, tumor growth inhibition, pancreatic cancer, non-small cell lung cancer, small cell lung cancer, cervical cancer, kidney cancer, colon cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2338853933
FWCI: 0.417
Cites: 15
Cited by: 24
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security